May 06, 2025 7:00am EDT HeartBeam Announces Two New U.S. Patents, Powering Forward Its Robust Patent Portfolio
May 05, 2025 7:00am EDT HeartBeam Appoints CEO Robert Eno to Board of Directors to Support U.S. Commercialization and Growth
May 01, 2025 8:31am EDT HeartBeam to Host First Quarter 2025 Results Conference Call on Tuesday, May 13, 2025 at 4:30 p.m. Eastern Time
Apr 29, 2025 8:31am EDT HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology
Apr 24, 2025 8:31am EDT HeartBeam and AccurKardia Announce Strategic Collaboration to Advance Cardiac Monitoring Innovation
Mar 06, 2025 9:01am EST HeartBeam to Participate at Upcoming Conferences in Dana Point, California, March 16-21, 2025
Feb 27, 2025 8:31am EST HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time
Feb 25, 2025 4:01pm EST HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock
Feb 13, 2025 8:31am EST HeartBeam Announces Pricing of $10.0 Million Underwritten Public Offering of Common Stock